BioSig Technologies (BSGM) Competitors $1.11 +0.05 (+4.72%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BSGM vs. ECOR, MODD, TELA, HYPR, NTRB, LNSR, APT, BLAC, NSPR, and MLSSShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include electroCore (ECOR), Modular Medical (MODD), TELA Bio (TELA), Hyperfine (HYPR), Nutriband (NTRB), LENSAR (LNSR), Alpha Pro Tech (APT), Bellevue Life Sciences Acquisition (BLAC), InspireMD (NSPR), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. electroCore Modular Medical TELA Bio Hyperfine Nutriband LENSAR Alpha Pro Tech Bellevue Life Sciences Acquisition InspireMD Milestone Scientific BioSig Technologies (NASDAQ:BSGM) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk. Does the media prefer BSGM or ECOR? In the previous week, electroCore had 3 more articles in the media than BioSig Technologies. MarketBeat recorded 3 mentions for electroCore and 0 mentions for BioSig Technologies. electroCore's average media sentiment score of 0.37 beat BioSig Technologies' score of 0.00 indicating that electroCore is being referred to more favorably in the news media. Company Overall Sentiment BioSig Technologies Neutral electroCore Neutral Does the MarketBeat Community prefer BSGM or ECOR? electroCore received 62 more outperform votes than BioSig Technologies when rated by MarketBeat users. However, 70.34% of users gave BioSig Technologies an outperform vote while only 62.12% of users gave electroCore an outperform vote. CompanyUnderperformOutperformBioSig TechnologiesOutperform Votes10270.34% Underperform Votes4329.66% electroCoreOutperform Votes16462.12% Underperform Votes10037.88% Which has more volatility & risk, BSGM or ECOR? BioSig Technologies has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Is BSGM or ECOR more profitable? electroCore has a net margin of -66.84% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets BioSig Technologies-44,832.50% N/A -746.77% electroCore -66.84%-165.17%-78.53% Do analysts prefer BSGM or ECOR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AelectroCore 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, BSGM or ECOR? electroCore has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioSig Technologies$40K451.45-$29.04MN/AN/AelectroCore$21.28M3.49-$18.83M-$2.20-5.24 Do insiders and institutionals have more ownership in BSGM or ECOR? 7.2% of BioSig Technologies shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 9.3% of BioSig Technologies shares are owned by company insiders. Comparatively, 19.7% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryelectroCore beats BioSig Technologies on 10 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.32M$3.56B$5.50B$8.53BDividend YieldN/A1.61%5.13%4.14%P/E RatioN/A16.58116.1015.23Price / Sales451.4557.091,496.2597.74Price / CashN/A46.1739.7434.10Price / Book-3.353.504.775.07Net Income-$29.04M$89.83M$119.06M$225.46M7 Day Performance27.23%0.67%0.80%0.37%1 Month Performance256.45%13.87%5.65%3.57%1 Year Performance-75.98%17.61%36.75%29.43% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig TechnologiesN/A$1.11+4.7%N/A-75.9%$18.14M$40,000.000.0050Gap DownECORelectroCore1.5661 of 5 stars$12.01+8.2%N/A+86.6%$72.13M$21.28M-5.4650News CoverageHigh Trading VolumeMODDModular Medical3.6131 of 5 stars$2.21-1.8%$5.00+126.2%+81.8%$71.96MN/A-3.2539Positive NewsTELATELA Bio3.2635 of 5 stars$2.84-1.0%$10.00+252.1%-49.7%$70.19M$64.74M-1.65120Upcoming EarningsHYPRHyperfine2.8589 of 5 stars$0.96-2.0%$1.43+48.8%-22.8%$68.92M$11.94M-1.65190News CoveragePositive NewsNTRBNutriband0.7606 of 5 stars$6.17-2.8%N/A+163.6%$68.52M$1.80M-7.6210News CoverageLNSRLENSAR2.7775 of 5 stars$5.53+1.5%$8.00+44.7%+150.2%$64.19M$45.12M-3.54110News CoveragePositive NewsAPTAlpha Pro TechN/A$5.57-1.8%N/A+36.0%$62.24M$61.09M13.59120BLACBellevue Life Sciences AcquisitionN/A$11.03+0.2%N/A+5.3%$62.02MN/A0.00N/APositive NewsNSPRInspireMD2.0973 of 5 stars$2.48+1.2%$4.50+81.5%-34.5%$61.83M$6.20M-3.3550Upcoming EarningsAnalyst ForecastGap UpMLSSMilestone Scientific2.5369 of 5 stars$0.80+1.3%$1.25+56.3%-5.8%$61.78M$9.83M-11.4330Analyst ForecastNews CoverageHigh Trading Volume Related Companies and Tools Related Companies electroCore Competitors Modular Medical Competitors TELA Bio Competitors Hyperfine Competitors Nutriband Competitors LENSAR Competitors Alpha Pro Tech Competitors Bellevue Life Sciences Acquisition Competitors InspireMD Competitors Milestone Scientific Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BSGM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
